- New therapeutic aspects of steroidal cardiac glycosides: the anticancer properties of Huachansu and its main active constituent Bufalin
Chien-shan Cheng et al, 2019, Cancer Cell International CrossRef - Bufalin serves as a pharmaceutic that mitigates drug resistance
Linxuan Miao et al, 2023, Drug Metabolism Reviews CrossRef - In silico analysis of the potential mechanism of telocinobufagin on breast cancer MCF-7 cells
Yi-wu Dang et al, 2018, Pathology - Research and Practice CrossRef - Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression
Jie Wang et al, 2018, Oncotarget CrossRef - Bufalin: A Systematic Review of Research Hotspots and Antitumor Mechanisms by Text Mining and Bioinformatics
Xian Zhang et al, 2020, The American Journal of Chinese Medicine CrossRef - Combinational Antitumor Strategies Based on the Active Ingredients of Toad Skin and Toad Venom
Huan Tian et al, 2024, Drug Design, Development and Therapy CrossRef - Iron oxide-alginate-berbamine nanocomposites trigger reactive oxygen species-induced apoptosis through down-regulation of PI3K/AKT signaling in human bladder cancer cells
Huajun Zhang et al, 2022, Process Biochemistry CrossRef - Bufalin for an innovative therapeutic approach against cancer
Laura Soumoy et al, 2022, Pharmacological Research CrossRef - Bufalin induced apoptosis of bladder carcinoma cells through the inactivation of Na+K+‑ATPase
Huang Houbao et al, 2018, Oncology Letters CrossRef - A research update on the antitumor effects of active components of Chinese medicine ChanSu
Jinhao Jia et al, 2022, Frontiers in Oncology CrossRef - Bufalin Suppresses Colorectal Cancer Cells by the Blockade of Canonical Wnt Signaling Pathway
Wanmi Sui et al, 2022, 2022 4th International Conference on Intelligent Medicine and Image Processing CrossRef - An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
Qingmei Ye et al, 2023, Frontiers in Pharmacology CrossRef - Proscillaridin A Sensitizes Human Colon Cancer Cells to TRAIL-Induced Cell Death
Manami Semba et al, 2022, International Journal of Molecular Sciences CrossRef - Bufalin inhibits human diffuse large B-cell lymphoma tumorigenesis by inducing cell death through the Ca2+/NFATC1/cMYC pathway
Jincheng Song et al, 2021, Carcinogenesis CrossRef - Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment
Li-Juan Deng et al, 2020, European Journal of Pharmacology CrossRef - Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs
Ammad Ahmad Farooqi et al, 2023, Molecules CrossRef - TRAIL-mediated signaling in bladder cancer: realization of clinical efficacy of TRAIL-based therapeutics in medical oncology
Ammad Ahmad Farooqi et al, 2023, Medical Oncology CrossRef